Dentistry and the myasthenia gravis patient: a review of the current state of the art.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oral surgery, oral medicine, oral pathology and oral radiology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.tripleo.2011.08.023PMID 22732850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proton magnetic resonance spectroscopy of the intrinsic tongue muscles in patients with myasthenia gravis with different autoantibodies

  2011cited by this paper
• Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.

  2011cited by this paper
• The Incidence of Myasthenia Gravis: A Systematic Literature Review

  2010cited by this paper
• Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis

  2010cited by this paper
• Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.

  2010cited by this paper
• Diagnostic value of double-step nerve stimulation test in patients with myasthenia gravis.

  2010cited by this paper
• Interleukin-10 promoter polymorphisms in myasthenia gravis.

  2009cited by this paper
• Successful treatment of refractory generalized myasthenia gravis with rituximab

  2009cited by this paper
• The ice pack test in the differential diagnosis of myasthenic diplopia.

  2009cited by this paper
• Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta.

  2009cited by this paper
• Periodic Therapeutic Plasma Exchange in Patients With Moderate to Severe Chronic Myasthenia Gravis Non‐Responsive to Immunosuppressive Agents: An Eight Year Follow‐Up

  2009cited by this paper
• Granzyme B: evidence for a role in the origin of myasthenia gravis.

  2008influential reference
• Tacrolimus for Myasthenia Gravis

  2008cited by this paper
• Tacrolimus for myasthenia gravis: a clinical study of 212 patients.

  2008cited by this paper
• Prolactin may be a promising therapeutic target for myasthenia gravis: hypothesis and importance.

  2008influential reference
• An unusual primary presentation of myasthenia gravis.

  2008cited by this paper
• Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children

  2008cited by this paper
• Medications and Myasthenia Gravis

  2007cited by this paper
• Does this patient have myasthenia gravis?

  2005cited by this paper
• Pulmonary function tests and blood gases in worsening myasthenia gravis

  2005cited by this paper
• Institutional report - Thoracic general CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings

  2005cited by this paper
• Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.

  2005cited by this paper
• Fewer thymic changes in MuSK antibody‐positive than in MuSK antibody‐negative MG

  2005cited by this paper
• Acetylcholine receptors loss and postsynaptic damage in MuSK antibody–positive myasthenia gravis

  2005cited by this paper
• Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy

  2004cited by this paper
• Update on myasthenia gravis

  2004cited by this paper
• Myasthenia gravis and pregnancy: clinical implications and neonatal outcome

  2004cited by this paper
• Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis

  2004cited by this paper
• Therapeutic vaccines in autoimmunity

  2004cited by this paper
• Clinical evaluation and management of myasthenia gravis

  2004cited by this paper
• Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer

  2003cited by this paper
• Suppression of EAMG in Lewis Rats by IL‐10‐Exposed Dendritic Cells

  2003cited by this paper
• Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report.

  2003cited by this paper
• Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

  2003cited by this paper
• Treatment of refractory myasthenia: “Rebooting” with high‐dose cyclophosphamide

  2003influential reference
• Adsorption Column for Myasthenia Gravis Treatment: MedisorbaMG‐50

  2003cited by this paper
• Mycophenolate Mofetil for Myasthenia Gravis A Double‐Blind, Placebo‐Controlled Pilot Study

  2003cited by this paper
• Specific Immunotherapy of Experimental Myasthenia by Genetically Engineered APCs

  2003cited by this paper
• Successful treatment of myasthenia gravis with tacrolimus

  2002cited by this paper
• Plasma exchange for generalised myasthenia gravis

  2002cited by this paper
• Masticatory performance in patients with myasthenia gravis.

  2002cited by this paper
• Mycophenolate mofetil for myasthenia gravis: An open-label pilot study

  2001cited by this paper
• Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis

  2001cited by this paper
• Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases

  2001cited by this paper
• Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

  2001cited by this paper
• Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

  2001cited by this paper
• Rituximab for myasthenia gravis developing after bone marrow transplant

  2000cited by this paper
• Myasthenia gravis associated with reduced masticatory function.

  2000cited by this paper
• Myasthenia gravis

  2000cited by this paper
• Anti-sense approach to anticholinesterase therapeutics.

  2000cited by this paper
• Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

  2000cited by this paper
• Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients.

  1999influential reference
• Therapy of myasthenic crisis.

  1998cited by this paper
• Fluoroquinolone antibiotics block neuromuscular transmission

  1998influential reference
• Clinical Aspects

  1998cited by this paper
• Myasthenia gravis: dental treatment considerations.

  1997influential reference
• Myasthenic crisis

  1997cited by this paper
• Oxford Textbook of Medicine

  1997cited by this paper
• Therapy of myasthenic crisis.

  1997cited by this paper
• [Exacerbation of myasthenia gravis by pefloxacin].

  1995influential reference
• Chronic mucocutaneous candidiasis.

  1994cited by this paper
• Myasthenia gravis.

  1994cited by this paper
• Masseter muscle fatigue during sustained clenching in subjects with complete dentures, implant-supported prostheses, and natural teeth.

  1993cited by this paper
• A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravis a

  1993cited by this paper
• Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.

  1991cited by this paper
• Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cells

  1990cited by this paper
• Myasthenia Gravis

  1990cited by this paper
• Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy

  1989cited by this paper
• Chronic mucocutaneous candidiasis

  1989cited by this paper
• Relationship between the values of masticatory efficiency and biting pressure in children with cerebral palsy--inter-relationship between the maximum biting pressure, chewing cycle and the value of masticatory efficiency.

  1988cited by this paper
• Long‐Term Corticosteroid Treatment of Myasthenia Gravis

  1987cited by this paper
• Histopathology of different types of atrophy of the human tongue.

  1987cited by this paper
• Ampicillin may aggravate clinical and experimental myasthenia gravis.

  1986cited by this paper
• Chronic mucocutaneous candidiasis.

  1983cited by this paper
• Dental management of a child with severe myasthenia gravis.

  1983cited by this paper
• Glucocorticosteroids in dentistry.

  1982cited by this paper
• Glucocorticosteroids in Dentistry

  1982cited by this paper
• Current concepts in the surgical treatment of patients with myasthenia gravis.

  1981cited by this paper
• THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURES

  1981cited by this paper
• Electromyographic activity of masticatory muscles in patients with progressive muscular dystrophy (Duchenne type): relation between integrated electromyographic activity and biting force.

  1981cited by this paper
• Prosthodontic failures in patients with systemic disorders.

  1979cited by this paper
• Management of patients with myasthenia gravis who require maxillary dentures.

  1977cited by this paper
• Plasma exchange in myasthenia gravis.

  1977cited by this paper
• Myasthenia Gravis

  1975influential reference
• Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

  1974cited by this paper
• The otolaryngologist's role in myasthenia gravis.

  1972cited by this paper
• Thymectomy in juvenile myasthenia gravis.

  1971influential reference
• THE PATHOLOGY OF THE THYMUS GLAND IN MYASTHENIA GRAVIS

  1966cited by this paper
• MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED

  1939cited by this paper

• The role of dentists in the recognition of neurodegenerative and systemic conditions with neurological involvement.

  2026cites this paper
• Surgical Treatment of the Oroantral Fistula in a Patient with Myasthenia Gravis: Clinical Considerations and Anesthetical Management

  2024cites this paper
• Complete mouth rehabilitation with fixed implant-supported restoration for a patient with myasthenia gravis: A clinical report.

  2023cites this paper
• The Dental Management of Pediatric Patient Diagnosed with Myasthenia Gravis: A Case Report

  2022cites this paper
• Odontogenic fibromyxoma: A case report in myasthenia gravis patient and review of the literature

  2022cites this paper
• Neurologic Diseases

  2021cites this paper
• Review of general and head and neck/oral and maxillofacial features of Charcot-Marie-Tooth disease and dental management considerations.

  2021cites this paper
• Oral function in ALS and other neurodegenerative diseases

  2020cites this paper
• Exploring Factors Influencing Complete Denture Management of Patient with Myasthenia Gravis

  2020cites this paper
• Thymoma associated myasthenia gravis with atypical presentation of lipomatous tongue atrophy: a case report

  2019cites this paper
• INFLAMMATORY COMPLICATIONS AFTER TOOTH EXTRACTION IN A PATIENT WITH MYASTHENIA GRAVIS - CASE REPORT

  2019cites this paper
• Anesthetic considerations for a patient with myasthenia gravis undergoing deep sedation in an outpatient oral surgery setting

  2019cites this paper
• First live learning event in Malmö Highlights from Paris 2016 Guided surgery : the next

  2018cites this paper
• The Neuromuscular diseases in Pediatric Dental Office

  2017cites this paper
• Linking medical and dental health record data: a partnership with the Rochester Epidemiology Project

  2017cites this paper
• An update on myasthenia gravis, challenging disease for the dental profession.

  2015influential citation